Two new groups have been formed in preparation for the application of the EU regulation on health technology assessment cooperation.
EUnetHTA21, a new consortium of health technology assessment (HTA) agencies, is preparing to launch the first open call to pharmaceutical companies that want to participate in upcoming joint scientific consultations. The call is part of the consortium’s work to prepare for the application of the new HTA regulation aimed at increasing EU-wide collaboration in this area.
The new consortium is the latest initiative of EUnetHTA, a voluntary cooperation between EU member states
Pharmaceutical industry organizations offered alternatives to tariffs that could maintain a secure domestic supply chain in public comments filed in response to a federal 232 investigation.
Cuts to the FDA’s policy and legal personnel have prevented dozens of product-specific guidances for generic drug development from being published.
The Oncologic Drugs Advisory Committee will meet for two days in mid-May, followed by a Vaccines and Related Biological Products Advisory Committee’s review of the 2025-2026 COVID-19 vaccine formulation.
